Partners
Partners

Partner 30 - Eli Lilly


Eli Lilly

Dr. Christoph Reinhard

 

Principal Investigator

Senior Director Translational Science Oncology

 

undefinedE-Mail

 

Eli Lilly & Company

 

Lilly House Priestley Road

Basingstoke

Hampshire RG24 9NL

United Kingdom

undefinedWebsite

Company presentation

Lilly was founded in 1876, with Headquarters located in Indianapolis, Indiana, U.S.A and with operations based in the US and EU, Eli Lilly is now the 10th largest pharmaceutical company in the world. Across the globe, Lilly has developed productive alliances and partnerships that advance our capacity to develop innovative medicines at lower costs. Eli Lilly is a research-based pharmaceutical company committed to create value for all stakeholders by accelerating the flow of innovative medicines that provide improved outcomes for individual patients and to help people live longer, healthier, more active lives.  
Eli Lilly employs approximately 38,000 people worldwide. Approximately 7,400 employees are engaged in research and development. Clinical research is being conducted in more than 55 countries, with research and development facilities located in 8 countries and manufacturing plants located in 13 countries. Lilly products are marketed in 125 countries.
Eli Lilly and Company has broad interest in Oncology with several marketed products in pancreatic, lung and colorectal cancer. Oncology drug development is focused on new medicines tailored for the most responsive patient population and has active biomarker research for most of the current pipeline projects. Eli Lilly and Company has developed deep expertise in next generation sequencing technologies in order to better understand molecular changes in cancer. The identification of clinically meaningful molecular subtypes and associated matching model systems is tightly linked to our biomarker discovery. A special interest in biomarker research is focused on liquid biopsies which could present a safer and more informative alternative to current tumour biopsies.

CANCER-ID Consortium

CANCER-ID consortium

CANCER-ID Workpackages

CANCER-ID Work Plan

EUROPA - NEWS

News from the European Comission

What's new in Health and Life Sciences? Click here for news from the European Commission.

Search
Top
Home
Menu

EU logo
imi Logo
efpia Logo

News Section

Hands-on courses provided by our member TATAA Read more

Social Media

LinkedIn Cancer-ID